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ABSTRACT 
 
BACKGROUND: Preeclampsia is one of the commonest complications of pregnancy. It is associated with a state 
of hypercoagulability. The present study aimed to estimate the plasma fibrinogen and plasma FDP levels in 
preeclampsiaas compared to normal pregnancies. METHODS: This is a case-control hospital based study with 
normal pregnant women (n=36) and women with preeclampsia (n=64) in their third trimester were included in the 
study. Preeclamptic group was classified in to mild (n=42) and severe (n=22) preeclampsia. Plasma fibrinogen and 
FDP levels were analysed, and compared between the groups. RESULTS: Preeclampsia and normal pregnancy 
groups were comparable for age and body mass index but preeclampsia group had higher blood pressures and less 
period of gestation (p<0.0001). The levels of plasma fibrinogen (654.5±131.74 vs. 491.52±81.7 mg/dL) and plasma 
FDP (10.96±2.32 vs. 5.54±0.8 µg/L) were higher in the preeclampsia group as compared to normal pregnancy 
(p<0.0001). Elevations in fibrinogen and FDP levels were more marked for severe preeclampsia group than mild 
preeclampsia group.CONCLUSION: Preeclampsia is associated with high fibrinogen and FDP levels as compared 
to normal pregnancies. Severe preeclampsia patients have greater elevations as compared to mild preeclampsia 
patients. 
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Introduction 
 
 
Preeclampsia is a systemic disease characterised by 
hypertension, oedema and proteinuria. Haematological, 
genetic and immunological factors play role in 
preeclampsia aetiopathogenesis. Fibrin deposit in 
vascular and endothelial area of many organs and 
placenta is the well known feature of this disease [1]. 
Preeclampsia is a major cause of maternal morbidity 
and mortality in the world. It develops in 5-8% of 
human pregnancies [2] .  
Normal pregnancy is associated with impressive 
changes in the haemostatic mechanism and is a 
hypercoagulable state associated with increase in many 
coagulation factors. 
_______________________________ 
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Coagulation and fibrinolytic systems undergo major 
alteration associated with reduced fibrinolytic activity 
and increased levels of fibrinogen and FDP in normal 
pregnancy which has been reported in many 
studies[3,4]. 
 It has been hypothesised that preeclampsia is a 
generalised intravascular inflammatory response, 
which occurs in normal pregnancy too, but is more 
exaggerated in preeclampsia [5] . Endothelial cell 
dysfunction and inflammation are considered to have a 
role in the pathophysiology of preeclampsia [6]. 
Mediators of an inflammatory response like plasma 
fibrinogen are altered in preeclamptic women. A 
systemic inflammatory response involves both the 
immune system and clotting and fibrinolytic system [7]  
.An excess of FDP with diminished or normal systemic 
fibrinolytic activity suggests that local intravascular 
fibrin deposition and fibrinolysis occur in 
preeclampsia. The high level of FDP is associated with 
the pathogenesis of the defective haemostasis in 
preeclampsia [8]. Increased fibrinolytic activity in 
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preeclampsia patients has been reported earlier, 
resulting in increased levels of FDP [9,10] . So this 
study intended to estimate the plasma fibrinogen and 
plasma fibrin degradation product (FDP) levels in 
preeclamptic pregnant women and compare them with 
normal pregnant women in their third trimester. 
Methods 
The subjects were pregnant women clinically 
diagnosed as preeclampsia during third trimester (28-
40 weeks) with the age 18-35 years visiting obstetrics 
OPD and wards of GEMS & Sridhar Hospital . Sixty-
four consecutive preeclampsia patients were included 
in the study. Preeclmapsia patients were classified in to 
mild preeclampsia (n=42) and severe preeclampsia 
(n=22) women. As a control group 36 pregnant women 
without evidence of any illness were taken. The normal 
pregnant women were also in the third trimester (28-40 
weeks) of their pregnancy with the age 18-35 years. 
Inclusion criteria for women included in the study 
were: should not be using any kind of oral 
contraceptives, anticoagulant drugs, should be non-
smokers and non-alcoholics. Exclusion criteria were: 
past history of diabetes, systemic or endocrine disorder, 
chronic infection, chronic renal disease, previous 
history of hypertension, women in active labour, were 
excluded from the study.  
Preeclampsia was diagnosed according to American 
College of Obstetrics and Gynecology (ACOG) 
criteria: a blood pressure higher than 140/90 mm Hg 
and proteinuria more than 300 mg/24hour were 
observed on at least two occasions more than 6 hours 
apart after the 20th week of pregnancy. Preeclamspia 
was classified as severe if diastolic blood pressure 
increased to at least 110 mmHg, proteinuria >5000 mg 
per day and the presence of headache, visual 
disturbances, epigastric pain, oliguria, elevated liver 
function tests, elevated renal function tests, 
thrombocytopenia. 
Blood samples for plasma fibrinogen and FDP was 
collected into test tubes containing 1 ml of 3.8% 
sodium-citrate. Centrifugation of these specimens was 
done for ten minutes at room temperature and at 
2500xg. Plasma fibrinogen was estimated by Clauss 
method (Fib2) using Start analyzer -a compact 4-
channel coagulation instrument. The levels of FDP 
were investigated using latex immunoturbidimetric 
method based on the principle of ELISA. The results 
were expressed as mean ± SD and groups were 
compared. Statistical analysis was carried out by using 
SPSS software, version 20 with  significance at P < 
0.05. 
 
Results 
Maternal age and body mass index (BMI) were 
comparable in the preeclampsia and normal pregnancy 
groups (Table 1). Gestational age was lower while 
systolic and diastolic blood pressures were 
significantly (p<0.0001) higher in preeclamptic 
patients as compared to normal pregnant women (Table 
1).  
 
Table 1- Clinico-biochemical features in the normal and preeclampsia groups 
Parameters Normal 
pregnant women 
(n=36) 
Preeclamptic 
pregnant women 
(n=64) 
Mild preeclamptic 
pregnant women 
(n=42) 
Severe preeclamptic 
pregnant women 
(n=22) 
Age (years) 23±2.62 23.14±2.97 22.90±2.96 23.59±2.98 
BMI (kg/m2) 24.17±1.91 24.66±1.84 24.87±1.76 24.26±2.07 
Gestational age (weeks) 39.13±2.82 36.68±1.78 37.19±1.65 35.72±1.54 
Systolic blood pressure 
(mm of Hg) 
114.72±6.96 148.10±15.78 139.52±5.38 164.5±16.17 
Diastolic blood pressure 
(mm of Hg) 
74.44±5.03 100.15±12.11 94.04±7.26 111.81±10.97 
Plasma fibrinogen 
(mg/dL) 
491.52±81.7 654.5±131.74 616.02±124.65 727.95±118.91 
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Values  expressed as  Mean ±SD 
 
Average values of fibrinogen and FDP were higher for the preeclamptic pregnant patients as compared to normal 
pregnancy group (p<0.0001), although the normal pregnant group also showed elevated levels of fibrinogen than the 
normal range (200-400 mg/dL). Fibrinogen (727.95 vs 616.02 mg/dL, p<0.05) and FDP levels were significantly 
higher in severe preeclampsia group than in the mild preeclampsia group (12.28 vs. 10.27 µg/L, p<0.001). 
Discussion 
In the present study, the plasma fibrinogen and FDP 
levels were significantly higher in preeclampsia , more 
so in the severe preeclampsia women as compared to 
mild preeclampsia. Enhanced coagulation-fibrinolysis 
and coagulopathy are well known features of 
preeclampsia [11]. Fibrinogens are the major 
coagulation heterogeneous protein and it is 
symmetrical glycoprotein of 340 KDa  molecular 
weight. The results of our study showed  that in 
preeclampsia the level of plasma fibrinogen  was  
higher as compared to normal pregnancy and 
reconfirms the results from earlier studies[12,13]  .The 
increase of fibrinogen in preeclampsia results from the 
exaggerated inflammatory response and subsequent 
endothelial dysfunction and activation which are 
currently believed to be the key pathophysiological 
mechanism in preeclampsia [12]. The increase in 
fibrinogen in normal pregnancy is also due to the 
inflammatory responses which explain that fibrinogen 
is the acute phase reactant-marker of inflammation, in 
both normal pregnancy and preeclamptic pregnancy. 
The increase of fibrinogen in normal pregnancy may 
also be due to utilisation in uteroplacental circulation, 
enhanced synthesis and also due to hormonal changes 
like oestrogen synthesis [14]. 
Fibrin degradation products (FDP) are components of 
the blood produced by clot degeneration. These are the 
substances left behind when clots dissolve in the blood. 
These are produced by the action of plasmin 
(proteolytic enzymes) on deposited fibrin. Excess FDP 
can cause severe haemostatic defects [15]. High plasma 
FDP levels in our preeclamptic patients are in 
agreement with the finding of others [16,17].   In this 
study, raised plasma FDP levels indicate increase in 
fibrinolytic activity  and  concurs with the previous  
finding  which showed an  intravascular coagulation 
disturbance observed in patients with preeclampsia 
[17,18]. However, more research in this field is to be 
carried out. 
Our study concluded that increase in plasma fibrinogen 
explains it to be an acute phase reactant indicating the 
exaggerated inflammatory responses in preeclampsia 
and the endothelial activation which are believe to be 
the pathophysiological mechanism in preeclampsia. 
Also the elevated FDP indicates the increased 
intravascular coagulation in preeclampsia and 
increased in fibrinolytic activity. Both are thus the 
complementary predictors explaining the severity of 
the disease.  
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